Published in ACS Chem Neurosci on January 30, 2012
Increased vesicular monoamine transporter enhances dopamine release and opposes Parkinson disease-related neurodegeneration in vivo. Proc Natl Acad Sci U S A (2014) 1.63
Mesolimbic dopamine signals the value of work. Nat Neurosci (2015) 1.27
Rapid, sensitive detection of neurotransmitters at microelectrodes modified with self-assembled SWCNT forests. Anal Chem (2012) 1.09
Microfluidic systems for studying neurotransmitters and neurotransmission. Lab Chip (2013) 0.91
High temporal resolution measurements of dopamine with carbon nanotube yarn microelectrodes. Anal Chem (2014) 0.90
Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. Neurobiol Dis (2014) 0.90
Sampling phasic dopamine signaling with fast-scan cyclic voltammetry in awake, behaving rats. Curr Protoc Neurosci (2015) 0.86
Emerging trends in in vivo neurochemical monitoring by microdialysis. Curr Opin Chem Biol (2013) 0.82
Kinetics of the dopamine transporter in Drosophila larva. ACS Chem Neurosci (2013) 0.81
A novel restricted diffusion model of evoked dopamine. ACS Chem Neurosci (2014) 0.81
In situ electrode calibration strategy for voltammetric measurements in vivo. Anal Chem (2013) 0.77
Enhanced Dopamine Release by Dopamine Transport Inhibitors Described by a Restricted Diffusion Model and Fast-Scan Cyclic Voltammetry. ACS Chem Neurosci (2016) 0.77
Vesicular Monoamine Transporter 2 (VMAT2) Level Regulates MPTP Vulnerability and Clearance of Excess Dopamine in Mouse Striatal Terminals. Toxicol Sci (2016) 0.76
An update of the classical and novel methods used for measuring fast neurotransmitters during normal and brain altered function. Curr Neuropharmacol (2014) 0.75
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature (1996) 7.26
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Functional and spatial segregation of secretory vesicle pools according to vesicle age. Nature (2003) 2.55
Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience (1988) 2.43
Subsecond adsorption and desorption of dopamine at carbon-fiber microelectrodes. Anal Chem (2000) 2.29
Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci (2009) 2.16
Determination of release and uptake parameters from electrically evoked dopamine dynamics measured by real-time voltammetry. J Neurosci Methods (2001) 2.03
Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J Neurochem (2003) 1.95
Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology (2007) 1.68
Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction. Anal Chem (2008) 1.66
Comparison of dopamine uptake in the basolateral amygdaloid nucleus, caudate-putamen, and nucleus accumbens of the rat. J Neurochem (1995) 1.62
Regulation of quantal size by presynaptic mechanisms. Rev Neurosci (2000) 1.60
Color images for fast-scan CV measurements in biological systems. Anal Chem (1998) 1.58
Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J Pharmacol Exp Ther (1995) 1.53
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci U S A (2008) 1.52
Response times of carbon fiber microelectrodes to dynamic changes in catecholamine concentration. Anal Chem (2002) 1.52
In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus. Eur J Neurosci (2009) 1.35
Carbon fibre microelectrodes. J Neurosci Methods (1979) 1.34
Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res (1984) 1.34
Dopamine uptake: a review of progress in the last decade. Prog Neurobiol (1990) 1.31
Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease. J Neurochem (2006) 1.29
Higher sensitivity dopamine measurements with faster-scan cyclic voltammetry. Anal Chem (2011) 1.29
Disparity between tonic and phasic ethanol-induced dopamine increases in the nucleus accumbens of rats. Alcohol Clin Exp Res (2009) 1.22
Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. J Pharmacol Exp Ther (1988) 1.20
In vivo electrochemical detection of catechols in the neostriatum of anaesthetized rats: dopamine or DOPAC? Nature (1980) 1.14
Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry. Neuroscience (1994) 1.11
Synapsins differentially control dopamine and serotonin release. J Neurosci (2010) 1.07
Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo. J Neurochem (1995) 1.04
Temporal characterization of perfluorinated ion exchange coated microvoltammetric electrodes for in vivo use. Anal Chem (1987) 1.01
Characterization of amperometry for in vivo measurement of dopamine dynamics in the rat brain. Talanta (1994) 0.90
Measuring uptake rates in intact tissue. Methods Enzymol (1998) 0.78
Subsecond dopamine release promotes cocaine seeking. Nature (2003) 6.53
An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell (2005) 5.60
Associative learning mediates dynamic shifts in dopamine signaling in the nucleus accumbens. Nat Neurosci (2007) 4.97
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression. Neuron (2005) 4.78
Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci (2003) 4.50
Desensitization of G protein-coupled receptors and neuronal functions. Annu Rev Neurosci (2004) 4.44
Dopamine operates as a subsecond modulator of food seeking. J Neurosci (2004) 3.79
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci U S A (2004) 3.60
Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science (2003) 3.52
Real-time measurement of dopamine fluctuations after cocaine in the brain of behaving rats. Proc Natl Acad Sci U S A (2005) 3.49
Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. Annu Rev Pharmacol Toxicol (2002) 3.45
Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. J Biol Chem (2002) 3.40
Food reward in the absence of taste receptor signaling. Neuron (2008) 3.37
Resolving neurotransmitters detected by fast-scan cyclic voltammetry. Anal Chem (2004) 3.18
Overoxidation of carbon-fiber microelectrodes enhances dopamine adsorption and increases sensitivity. Analyst (2003) 3.04
Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron (2004) 2.76
Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol (2002) 2.76
A beta-arrestin 2 signaling complex mediates lithium action on behavior. Cell (2008) 2.76
Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli. Nat Neurosci (2008) 2.76
Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science (2004) 2.64
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A (2003) 2.62
Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol (2009) 2.60
Detecting subsecond dopamine release with fast-scan cyclic voltammetry in vivo. Clin Chem (2003) 2.58
Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol (2002) 2.54
Monitoring rapid chemical communication in the brain. Chem Rev (2008) 2.48
The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem (2002) 2.47
Building a new conceptual framework for receptor heteromers. Nat Chem Biol (2009) 2.41
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci (2007) 2.28
Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A (2008) 2.23
Regional specificity in the real-time development of phasic dopamine transmission patterns during acquisition of a cue-cocaine association in rats. Eur J Neurosci (2009) 2.22
The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci (2007) 2.22
Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron (2006) 2.19
Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci (2009) 2.16
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol (2005) 2.14
Rapid dopamine signaling in the nucleus accumbens during contingent and noncontingent cocaine administration. Neuropsychopharmacology (2005) 2.14
Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats. J Neurosci (2004) 2.10
Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron (2003) 2.03
Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci (2002) 2.01
MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction. Proc Natl Acad Sci U S A (2009) 2.00
Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron (2006) 1.98
Discovery of β-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy. Proc Natl Acad Sci U S A (2011) 1.98
Preferential enhancement of dopamine transmission within the nucleus accumbens shell by cocaine is attributable to a direct increase in phasic dopamine release events. J Neurosci (2008) 1.97
Phasic nucleus accumbens dopamine encodes risk-based decision-making behavior. Biol Psychiatry (2011) 1.96
Real-time decoding of dopamine concentration changes in the caudate-putamen during tonic and phasic firing. J Neurochem (2003) 1.95
Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation. J Neurosci (2007) 1.95
Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J Neurosci (2005) 1.94
Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. J Neurosci (2007) 1.93
Extinction of cocaine self-administration reveals functionally and temporally distinct dopaminergic signals in the nucleus accumbens. Neuron (2005) 1.90
Correlation of local changes in extracellular oxygen and pH that accompany dopaminergic terminal activity in the rat caudate-putamen. J Neurochem (2003) 1.89
Spinal cord stimulation restores locomotion in animal models of Parkinson's disease. Science (2009) 1.88
Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci (2006) 1.88
Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity. Mol Pharmacol (2010) 1.86
Dynamic gain control of dopamine delivery in freely moving animals. J Neurosci (2004) 1.86
Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci U S A (2008) 1.85
Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS Biol (2011) 1.84
Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron (2007) 1.84
N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity. Neuropsychopharmacology (2007) 1.83
In vivo comparison of norepinephrine and dopamine release in rat brain by simultaneous measurements with fast-scan cyclic voltammetry. J Neurochem (2011) 1.81
Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc Natl Acad Sci U S A (2004) 1.78
Dopaminergic control of sleep-wake states. J Neurosci (2006) 1.77
Dynamic changes in accumbens dopamine correlate with learning during intracranial self-stimulation. Proc Natl Acad Sci U S A (2008) 1.77
Phasic nucleus accumbens dopamine release encodes effort- and delay-related costs. Biol Psychiatry (2010) 1.68
Oligomerization and trafficking of the human dopamine transporter. Mutational analysis identifies critical domains important for the functional expression of the transporter. J Biol Chem (2002) 1.67
Dopamine detection with fast-scan cyclic voltammetry used with analog background subtraction. Anal Chem (2008) 1.66
Industrial toxicants and Parkinson's disease. Neurotoxicology (2012) 1.65
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands. J Biol Chem (2009) 1.60
Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. J Biol Chem (2002) 1.59
Carbon microelectrodes with a renewable surface. Anal Chem (2010) 1.56
Neural encoding of cocaine-seeking behavior is coincident with phasic dopamine release in the accumbens core and shell. Eur J Neurosci (2009) 1.56
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proc Natl Acad Sci U S A (2011) 1.55
Functional microcircuitry in the accumbens underlying drug addiction: insights from real-time signaling during behavior. Curr Opin Neurobiol (2004) 1.55
Real-time measurements of phasic changes in extracellular dopamine concentration in freely moving rats by fast-scan cyclic voltammetry. Methods Mol Med (2003) 1.53
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci U S A (2008) 1.52
Response times of carbon fiber microelectrodes to dynamic changes in catecholamine concentration. Anal Chem (2002) 1.52
Multivariate concentration determination using principal component regression with residual analysis. Trends Analyt Chem (2009) 1.52
Aberrant responses in social interaction of dopamine transporter knockout mice. Behav Brain Res (2004) 1.52
Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice. Exp Neurol (2002) 1.51
Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice. J Neurosci (2003) 1.49
Frequency of dopamine concentration transients increases in dorsal and ventral striatum of male rats during introduction of conspecifics. J Neurosci (2002) 1.47
Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. Science (2004) 1.47
PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. J Neurosci (2009) 1.46
Vmat2 heterozygous mutant mice display a depressive-like phenotype. J Neurosci (2007) 1.45
Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J Biol Chem (2003) 1.45
Simultaneous dopamine and single-unit recordings reveal accumbens GABAergic responses: implications for intracranial self-stimulation. Proc Natl Acad Sci U S A (2005) 1.44
Phosphoinositide 3-kinase regulates beta2-adrenergic receptor endocytosis by AP-2 recruitment to the receptor/beta-arrestin complex. J Cell Biol (2002) 1.40
Trace amine-associated receptor 1 partial agonism reveals novel paradigm for neuropsychiatric therapeutics. Biol Psychiatry (2012) 1.39
Novelty seeking and stereotypic activation of behavior in mice with disruption of the Dat1 gene. Neuropsychopharmacology (2005) 1.39
A beta-arrestin binding determinant common to the second intracellular loops of rhodopsin family G protein-coupled receptors. J Biol Chem (2005) 1.38
Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Mol Cell Biol (2006) 1.38
Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens. J Neurochem (2012) 1.37
Basolateral amygdala modulates terminal dopamine release in the nucleus accumbens and conditioned responding. Biol Psychiatry (2009) 1.36
In vivo voltammetric monitoring of norepinephrine release in the rat ventral bed nucleus of the stria terminalis and anteroventral thalamic nucleus. Eur J Neurosci (2009) 1.35
Cocaine cues drive opposing context-dependent shifts in reward processing and emotional state. Biol Psychiatry (2011) 1.34
Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization. Nat Methods (2007) 1.32
RNA editing induces variation in desensitization and trafficking of 5-hydroxytryptamine 2c receptor isoforms. J Biol Chem (2003) 1.32